Amelioration of cadmium-induced cardiac impairment by taurine

Chemico-Biological Interactions

Volumn 174, Issue 2, 2008, Pages 88-97

  Manna, Prasenjit ^a   Sinha, Mahua ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Antioxidant; Cadmium; Cardiac dysfunction; Cardiac protection; Taurine

Indexed keywords

ASCORBIC ACID; CADMIUM CHLORIDE; CARBONYL DERIVATIVE; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; SUPEROXIDE DISMUTASE; TAURINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; BLOOD LEVEL; CELL METABOLISM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA FRAGMENTATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; ENZYME ACTIVITY; HEART DISEASE; HEART PROTECTION; HISTOPATHOLOGY; IRON BLOOD LEVEL; MALE; MOUSE; NONHUMAN; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CADMIUM CHLORIDE; CHEMOPREVENTION; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; ENZYMES; HEART; HEART DISEASES; MALE; MICE; MYOCARDIUM; OXIDATIVE STRESS; TAURINE;

MURINAE; MUS;

EID: 46149086734     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.05.005     Document Type: Article

References (60)

1. Morselt A.F. Environmental pollutants and diseases. A cell biological approach using chronic cadmium exposure in the animal model as a paradigm case. Toxicology 70 (1991) 1-132
2. WHO. Environmental Health Criteria 134, Cadmium. 1st ed. (1992), World Health Organization, Geneva, Switzerland
3. WHO. Air Quality Guidelines (1987), WHO Regional Office for Europe, Copenhagen
4. Patrick L. Toxic metals and antioxidants. Part II. The role of antioxidants in arsenic and cadmium toxicity. Altern. Med. Rev. 8 (2003) 106-128
5. Lee J., Heng D., Chia K.S., Chew S.K., Tan B.Y., and Hughes K. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int. J. Epidemiol. 30 (2001) 983-988
6. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Cir. Res. 99 (2006) 692-705
7. Subramanyam G., Bhaskar M., and Govindappa S. The role of cadmium in induction of atherosclerosis in rabbits. Ind. Heart J. 44 (1992) 177-180
8. Sroczynski J., Biskupek K., Piotrowski J., and Rudzki H. Effect of occupational exposure to lead, zinc and cadmium on various indicators of the circulatory system of metallurgical workers. Med. Pr. 41 (1990) 152-158
9. Smetana R., Glogar D., Weidinger F., and Meisinger V. Heavy metal and trace element deviations. A comparison of idiopathic dilated cardiomyopathy and coronary heart diseases. Wien. Med. Wochenschr. 137 (1987) 553-557
10. Szuster-Ciesielska A., Stachura A., Slotwinska M., Kaminska T., Sneizko R., Paduch R., Abramczyk D., Filar J., and Kandefer-Szerszen M. The inhibitory effect of zinc on cadmium-induced cell apoptosis and reactive oxygen species (ROS) production in cell cultures. Toxicology 145 (2000) 159-171
11. Huxtable R.J. Physiological action of taurine. Physiol. Rev. 72 (1992) 101-163
12. Wessberg P., Hedner T., Hedner J., and Jonason. Effects of taurine and taurine antagonists on some respiratory and cardiovascular parameters. Life Sci. 33 (1983) 1649-1656
13. Timbrell J.A., Seabra V., and Watereld C.J. The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 26 (1995) 453-462
14. Wright C.E., Tallan H.H., and Linn Y.Y. Taurine: biological update. Ann. Rev. Biochem. 55 (1986) 427-453
15. Takahashi K., Ohyabu Y., Takahashi K., Solodushko V., Takatani T., Itoh T., Schaffer S.W., and Azuma J.J. Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes. Cardiovasc. Pharmacol. 41 (2003) 726-733
16. Chahine R., and Feng J. Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart. Arzneimittelforschung 48 (1998) 360-364
17. Birdsall T.C. Therapeutic applications of taurine. Altern. Med. Rev. 3 (1998) 128-136
18. Takahashi K., Ohyabu V., Takahashi K., Solodushko V., Takatani T., Itoh T., Schaffer S.W., and Azuma J. Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes. J. Cardiovasc. Pharmacol. 41 (2003) 726-733
19. Kondo Y., Murakami S., Oda H., and Nagate T. Taurine reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Adv. Exp. Med. Biol. 483 (2000) 123-126
20. Huxtable R.J., and Lippincott S.E. Diet and biosynthesis as sources of taurine in the mouse. J. Nutr. 112 (1982) 1003-1010
21. Pari L., Murugavel P., Sitasawad S.L., and Kumar K.S. Cytoprotective and antioxidant role of diallyl tetrasulfide on cadmium induced renal injury: an in vivo and in vitro study. Life Sci. 80 (2007) 650-658
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
23. Benzie I.F.F., and Strain J.J. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 299 (1999) 15-27
24. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
25. Uchida K., and Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J. Biol. Chem. 268 (1993) 6388-6393
26. Nishikimi M., Rao N.A., and Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 46 (1972) 849-854
27. Kakkar P., Das B., and Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Ind. J. Biochem. Biophys. 21 (1984) 130-132
28. Bonaventura J., Schroeder W.A., and Fang S. Human erythrocyte catalase: an improved method of isolation and a revaluation of reported properties. Arch. Biochem. Biophys. 150 (1972) 606-617
29. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
30. Smith I.K., Vierheller T.L., and Thorne C.A. Assay of glutathione reductase in crude tissue homogenates using 5,5′-dithiobis (2-nitrobenzoic acid). Anal. Biochem. 175 (1988) 408-413
31. Flohe L., and Gunzler W.A. Assay of glutathione peroxidase. Methods Enzymol. 105 (1984) 114-121
32. Lee C.Y. Glucose-6-phosphate dehydrogenase from mouse. Methods Enzymol. 89 (1982) 252-257
33. Ellman G.L. Tissue sulfhydryl group. Arch. Biochem. Biophys. 82 (1959) 70-77
34. Hissin P.J., and Hilf R.A. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74 (1976) 214-226
35. Sedlak J., and Lindsay R.H. Estimation of total, protein-bound, and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 24/25 (1958) 192-205
36. Lin K.T., Xue J.Y., Sun F.F., and Wong P.Y.K. Reactive oxygen species participate in peroxinitrile induced apoptosis in HL 60 cells. Biochem. Biophys. Res. Commun. 230 (1997) 115-119
37. Sellins K.S., and Cohen J.J. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139 (1987) 3199-3206
38. http://www.healingdaily.com/detoxification-diet/taurine.htm
39. Casalino E., Calzaretti G., Sblano C., and Landriscina C. Molecular inhibitory mechanisms of antioxidant enzymes in rat liver and kidney by cadmium. Toxicology 179 (2002) 37-50
40. Casalino E., Sblano C., and Landriscina C. Enzyme activity alteration by cadmium administration to rats: the possibility of iron involvement in lipid peroxidation. Arch. Biochem. Biophys. 346 (1997) 171-179
41. Chen L., Zhou J., Gao W., and Jiang Y.Z. Action of NO and TNF-alpha release of rats with cadmium loading in malfunction of multiple system organ. Sheng Li Xue Bao 25/55 (2003) 535-540
42. Cavicchi M., Gibbs L., and Whittle B.J. Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors. Gut 47 (2000) 771-778
43. Wang Z., and Templeton D.M. Induction of c-fos protooncogene in mesangial cells by cadmium. J. Biol. Chem. 273 (1998) 73-79
44. Jay D., Zamorano R., Munoz E., Gleason R., and Boldu J.L. Study of the interaction of cadmium with membranebound succinate dehydrogenase. J. Bioenerg. Biomembr. 23 (1991) 381-389
45. 2+ increase the cyclic GMP level in PC12 cells by inhibition of the cyclic nucleotide phosphodiesterase. Toxicology 157 (2001) 167-175
46. Lefer D.J., and Granger D.N. Oxidative stress and cardiac disease. Am. J. Med. 109 (2000) 315-323
47. Reiter R.J., and Tan D.X. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc. Res. 58 (2003) 10-19
48. Muller L. Consequences of cadmium toxicity in rat hepatocytes: mitochondrial dysfunction and lipid peroxidation. Toxicology 40 (1986) 285-295
49. Li W., Zhao Y., and Chou I.N. Alterations in cytoskeletal protein sulfhydryls and cellular glutathione in cultured cells exposed to cadmium and nickel ions. Toxicology 77 (1993) 65-79
50. Shukla G.S., Hussain T., and Chandra S.V. Possible role of regional superoxide dismutase activity and lipid peroxide levels in cadmium neurotoxicity: in vivo and in vitro studies in growing rats. Life Sci. 41 (1987) 2215-2221
51. Coogan T.P., Bare R.M., and Waalkes M.P. Cadmium-induced DNA strand damage in cultured liver cells: reduction in cadmium genotoxicity following zinc pretreatment. Toxicol. Appl. Pharmacol. 113 (1992) 227-233
52. Confod P., Baurer R., Danielsen E., Larsen E., and Bierrum M.J. 113Cd-NMR investigation of a cadmium-substitution copper, zinc-containing superoxide dismutase from yeast. Eur. J. Biochem. 198 (1991) 607-611
53. Redmond H.P., Wang J.H., and Bouchier-Hayes D. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. Arch. Surg. 131 (1996) 1287-1288
54. Cozzi R., Ricordy R., Bartolini F., et al. Taurine and ellagic acid: two differently acting natural antioxidants. Environ. Mol. Mutagen. 26 (1995) 248-254
55. Aruoma O.I., Halliwell B., Hoey B.M., and Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem. J. 256 (1988) 251-255
56. Gordon R.E., and Heller R.F. Taurine protection of lungs in hamster models of oxidant injury: a morphologic time study of paraquat and bleomycin treatment. In: Lombardini J.B., Schaffer S.W., and Azuma J. (Eds). Taurine: Nutritional Value and Mechanisms of Action (1992), Plenum Press, New York 319-323
57. Wright C.E., Tallan H.H., and Linn Y.Y. Taurine: biological update. Annu. Rev. Biochem. 55 (1986) 427-453
58. Fraga C.G., Motchnik P.A., Shigenaga M.K., Helbock H.J., Jacob R.A., and Ames B.N. Ascorbic acid protects against endogenous oxidative damage in human sperm. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 11003-11006
59. Halliwell B., Wasil M., and Grootveld M. Biologically significant scavenging of the myeloperoxidase derived oxidant hypochlorous acid by ascorbic acid. FEBS Lett. 213 (1987) 15-17
60. Gupta P., and Kar A. Role of ascorbic acid in cadmium induced thyroid dysfunction and lipid peroxidation. J. Appl. Toxicol. 18 (1998) 317-320